Chocamine, the other component of the Methyl-AMP Complex, is a specially standardized cocoa extract comprised of several different important constituents that enhance mood, cognitive awareness, and muscle contraction. PEA, tyramine, and L-Tyrosine are the most prevalent constituents of chocamine, and have the biggest impact on the positive effects of the compound. The amino acid tyrosine has profound psycho-stimulant effects for maximal cognitive enhancement- Tyrosine is a precursor to the neurotransmitter dopamine, and in human subjects tyrosine (and Chocamine) supplementation causes increased dopamine and norepinephrine levels, which can be helpful for increasing athletic ability and cognitive function. Tyrosine has the ability to ward off exercise-related fatigue by creating a favorable dopamine to serotonin ratio, which can alter the psychological profile of fatigue for the user. A simple shift in amino acid ratio can create a large difference in perception and concentration, and higher dopamine levels are highly correlated with increased focus and mental connection, along with some mood enhancement/anti-depressant activities. Tyrosine has been shown to reduce or prevent stress-related cognitive impairment, along with preventing the oversecretion of glucocorticoids.
Phenylethylalanine (PEA) and tyramine are two more important constituents of Chocamine. PEA is a biogenic amine derived from the amino acid phenylalanine, and it has some effects very similar to amphetamine. It has strong mood-enhancing qualities, along with the ability to increase focus and offset lack of sleep. Tyramine is another biogenic amine found in Chocamine- it is responsible for the increased release of NE in the neurons, creating an excitatory effect on the CNS. It has also been shown to increase dopamine levels and increase the generation of cAMP, and also to aid in lipolysis (another added bonus of this product). Chocamine also contains significant amounts of caffeine and theobromine, both of which also add a psycho-motor stimulatory effect, thus resulting in increased peripheral vasodilation, muscle contractility, and the mind/muscle stimulatory link!!!
Ready to rev up your workout? RPM takes the guesswork out of your supplementation. Finally there is 1 product that will make selecting your supplements easy. RPM does it all and does it effectively. You feel it from the very first dose. RPM is backed by proven scientific research that will have you reaching your goals in no time. With RPM….. everyday is race day!
Tian L, Xin ZC, Yuan YM, Fu J, Liu WJ, Wang LL. Zhonghua Yi Xue Za Zhi. 2004 Jun 2;84(11):954-7. Effects of icariin on the erectile function and expression of nitrogen oxide synthase isoforms in corpus cavernosum of arterigenic erectile dysfunction rat model
Xin ZC, Kim EK, Lin CS, Liu WJ, Tian L, Yuan YM, Fu J. Asian J Androl. 2003 Mar;5(1):15-8. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities.
Tian L, Xin ZC, Yuan YM, Fu J, Liu WJ, Wang LL. Zhonghua Yi Xue Za Zhi. 2004 Jan 17;84(2):142-5. [Article in Chinese] Effects of icariin on intracavernosal pressure and systematic arterial blood pressure of rat
Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav. 2004 Nov 15;83(2):291-307
Pavone C, Curto F, Anello G, Serretta V, Almasio PL, Pavone-Macaluso M. J Urol. 2004 Dec;172(6 Pt 1):2347-9. Prospective, crossover comparison of sublingual apomorphine (3mg) with oral sildenafil (50mg) for male erectile dysfunction.
Kruger TH, Haake P, Hartmann U, Schedlowski M, Exton MS. Orgasm-induced prolactin secretion: feedback control of sexual drive? Neurosci Biobehav Rev. 2002 Jan;26(1):31-44.
Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H. BJU Int. 1999 Feb;83(3):269-73. Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study.
Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U. Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int. 1999;63(4):220-3. PMID: 10743698
Stanislavov R, Nikolova V. Treatment of erectile dysfunction with pycnogenol and L-arginine. J Sex Marital Ther. 2003 May-Jun;29(3):207-13. PMID: 12851125
Kim NN, Christianson DW, Traish AM. Role of arginase in the male and female sexual arousal response. J Nutr. 2004 Oct;134(10 Suppl):2873S-2879S; discussion 2895S. Review. PMID: 15465804
Ying, Pan, Wei-Yun Zhang, Xing Xia, and Ling-Dong Kong, “Effects of Icariin on Hypothalamic-Pituitary-Adrenal Axis Action and Cytokine Levels in Stressed Sprague-Dawley Rats” Biol. Pharm. Bull., Vol. 29, 2399-2403.
Aghdasi B, Reid MB, and Hamilton SL. (1997) Nitric oxide protects the skeletal muscle Ca2+ release channel from oxidation induced activation. J Biol Chem 272:25462-25467
Balon TW, Nadler JL. (1997)Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol. 1997 Jan;82(1):359-63.
Etgen GJ Jr, Fryburg DA, Gibbs EM. (1997) Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes Nov;46(11):1915-9.
McAllister RM, Hirai T, Musch TI. (1995) Contribution of endothelium-derived nitric oxide (EDNO) to the skeletal muscle blood flow response to exercise. Med Sci Sports Exerc. Aug;27(8):1145-51
Wilson, JR and Kapoor S. (1993) Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans. J. Appl. Physiol. 75:2740-2744.
12. Young ME, Leighton B.(1998) Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle. Biochem J. Jan 1;329 ( Pt 1):73-9
Liu, HJ et al. [The effect of icariin and astragalosid I on the proliferation and differentiation of bone marrow stromal cells] Zhong Yao Cai. 2006 Oct;29(10):1062-5. Chinese.
PMID: 17326409 [PubMed - in process]
Ning, H et al. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006 Dec;68(6):1350-4.
PMID: 17169663 [PubMed - indexed for MEDLINE]
Jiang, Z. et al Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats. Biol Pharm Bull. 2006 Dec;29(12):2399-403.
PMID: 17142971 [PubMed - indexed for MEDLINE]
Zhang, Z. et al The testosterone mimetic properties of icariin. Asian J Androl. 2006 Sep;8(5):601-5. Epub 2006 Jun 5.
PMID: 16751992 [PubMed - indexed for MEDLINE]
Liu, W. Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats. Asian J Androl. 2005 Dec;7(4):381-8.
PMID: 16281085 [PubMed - indexed for MEDLINE]
Xin, ZC Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J Androl. 2003 Mar;5(1):15-8.
PMID: 12646997 [PubMed - indexed for MEDLINE]
Stanislavov, R. and Nikolova. 2003. Treatment of Erectile Dysfunction with Pycnogenol and L-arginine. Journal of Sex and Marital Therapy, 29(3): 207 – 213.
Alba-Roth J, Müller O, Schopohl J, von Werder K (1988). "Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion". J Clin Endocrinol Metab 67 (6): 1186-9.
Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. JPEN. 1986; 10:227-238.
Adams MR, McCredie R, Jessup W, et al. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis. 1997; 129:261-269.
Andres A, Morales JM, Praga M, et al. L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients. Nephrol Dial Transplant. 1997; 12:1437-1440.
Bode-Boger SM, Boger RH, Galland A, et al. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol. 1998; 46:489-497.
Isidori A, Lo Monaco A, Cappa M. A study of growth hormone release in man after oral administration of amino acids. Current Med Res Opinion. 1981; 7:475-481.
Wascher TC, Posch K, Wallner S, et al. Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase? Biochem Biophys Res Commun. 1997; 234:35-38.
Kijuma, I. et al Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Res. 2006 Jun 1;66(11):5960-7.
Sano, T. et al Anti-thrombotic effect of proanthocyanidin, a purified ingredient of grape seed. Thromb Res. 2005;115(1-2):115-21.
Eng, ET et al Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res. 2003 Dec 1;63(23):8516-22.
Fitzpatrick, DF et al Vasodilating procyanidins derived from grape seeds. Ann N Y Acad Sci. 2002 May;957:78-89.
Yu, H et al [Study of anti-atherosclerosic effect of grape seed extract and its mechanism] Wei Sheng Yan Jiu. 2002 Aug;31(4):263-5. Chinese.
Dell’Agli, H et al n vitro inhibition of human cGMP-specific phosphodiesterase-5 by polyphenols from red grapes.J Agric Food Chem. 2005 Mar 23;53(6):1960-5.
Sen, SK et al. Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm. Ann N Y Acad Sci. 2002 May;957:239-49. Review.
LeBail, JC et al Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities.Life Sci. 2001 Jan 5;68(7):751-61.
LeBail, JC et al Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells.
Life Sci. 2000 Feb 25;66(14):1281-91.
LeBail, JC et al Aromatase and 17beta-hydroxysteroid dehydrogenase inhibition by flavonoids. .Cancer Lett. 1998 Nov 13;133(1):101-6.
LeLain, L et al Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
Arayne, LS. Et al Grape fruit juice-drug interactions.Pak J Pharm Sci. 2005 Oct;18(4):45-57. Review.
Ho, PC et al. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.
J Pharm Pharm Sci. 2001 Sep-Dec;4(3):217-27.
Fuhr, U Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.
Br J Clin Pharmacol. 1993 Apr;35(4):431-6.
Jetter, A. et al Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther. 2002 Jan;71(1):21-9.
Nehlig, A; Daval JL, Debry G (1992 May-Aug). "Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic, and psychostimulant effects". Brain Res Brain Res Rev 17 (2):
Bolton, Ph.D., Sanford; Gary Null, M.S. (1981). Caffeine: Psychology, Use, and Abuse. Orthomolecular Psychiatry 10 (3): 202-211.
Newton, R; Broughton LJ, Lind MJ, Morrison PJ, Rogers HJ, Bradbrook ID (1981). "Plasma and salivary pharmacokinetics of caffeine in man". European Journal of Clinical Pharmacology 21 (1): 45-52.
Ortweiler, W; Simon HU, Splinter FK, Peiker G, Siegert C, Traeger A. (1985). "Determination of caffeine and metamizole elimination in pregnancy and after delivery as an in vivo method for characterization of various cytochrome p-450 dependent biotransformation reactions". Biomed Biochim Acta. 44 (7-8): 1189-99
Graham T, Rush J, van Soeren M (1994). "Caffeine and exercise: metabolism and performance.". Can J Appl Physiol 19 (2): 111-38.
Fredholm B, Bättig K, Holmén J, Nehlig A, Zvartau E (1999). "Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.". Pharmacol Rev 51 (1): 83-133
Verkhratsky A. (2005). "Physiology and Pathophysiology of the Calcium Store in the Endoplasmic Reticulum of Neurons". Physiol. Rev. 85 (1): 201-279.
Dews, P.B. (1984). Caffeine: Perspectives from Recent Research. Berlin: Springer-Valerag.
Ivy, JL; Costill DL, Fink WJ, Lower RW (1979 Spring). "Influence of caffeine and carbohydrate feedings on endurance performance". Med Sci Sports 11 (1): 6-11.
Graham, TE; Spriet, LL (1991 Dec). "Performance and metabolic responses to a high caffeine dose during prolonged exercise". J Appl Physiol 71 (6): 2292-8.
Trice, I; Haymes, EM (Mar 1995). "Effects of caffeine ingestion on exercise-induced changes during high-intensity, intermittent exercise". Int J Sport Nutr 5 (1): 37-44
Lieberman, HR, Corkin S, Spring BJ, Wurtman RJ, and Growden JH. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr 42: 366-370, 1985.
Banderet, LE, and Lieberman HR. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans. Brain Res Bull 22: 759-762, 1989.
Gelenberg AJ, Gibson CJ, Wojcik JD. Neurotransmitter precursors for the treatment of depression. Psychopharmacol Bull 1982;18:7-18.
Wurtman, RJ, and Lewis MC. Exercise, plasma composition and neurotransmission. In: Advances in Nutrition and Top Sport, edited by Brouns F.. Basel: Karger, 1991, vol. 32, p. 94-109.
Romanowski, W, and Grabiec S. The role of serotonin in the mechanism of central fatigue. Acta Physiol Pol 25: 127-134, 1974.
David L. Nelson, Michael M. Cox (2005). Lehninger Principles of Biochemistry. W.H. Freeman and Company, 435–439.
Sir Ghillean Prance, Mark Nesbitt (2004). The Cultural History of Plants. New York: Routledge.
William Gervase Clarence-Smith (2000). Cocoa and Chocolate, 1765-1914. London: Routledge, 10, 31.
Usmani O; Belvisi M, Patel H, Crispino N, Birrell M, Korbonits M, Korbonits D, Barnes P (2005). "Theobromine inhibits sensory nerve activation and cough.". FASEB J 19 (2): 231-3.
Serafini, M., Bugianesi, R., Maiani, G., Valtuena, S., De Santis, S. & Crozier, A. 2003. Plasma antioxidants from chocolate. Nature 424, 1013.
Kondo K, Hirano R, Matsumoto A, Igarashi O, Itakura H., Inhibition of LDL oxidation by cocoa, Lancet, November 1996; 348(2):1514.
MATISSEK R., Evaluation of xanthine derivatives in chocolate: nutritional and chemical aspects.
Smit HJ, Gaffan EA, Rogers PJ. (2004) Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology Nov;176(3-4):412-9.
Bitter Chocolate: Investigating the Dark Side of the World's Most Seductive Sweet, by Carol Off, Random House, 2006.
Chocolate, by the editors of Fine Cooking magazine, 2006.
The True History of Chocolate, by Sophie D. Coe & Michael D. Coe, Thames & Hudson, 1996.
Naked Chocolate, by David Wolfe and Shazzie, Rawcreation, 2005.
The Great Book of Chocolate, by David Lebovitz, Ten Speed Press, 2004.
The Chocolate Connoisseur, by Chloe Doutre-Roussel, Piatkus, 2005.
Green & Black's Chocolate Recipes, by Kyle Cathie Limited, 2003.